PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0022661|chronic kidney disease |
| Sentences | 122 |
| PubMedID- 23745333 | Some studies showed correlation between the elevated fgf-23 level and increased mortality from cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22269967 | Diagnosis of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22943818 | [the current situation and thoughts of cardiovascular disease in chronic kidney disease]. |
| PubMedID- 21288351 | The risk of cardiovascular disease is elevated in patients with chronic kidney disease (ckd) with an inverse graded relationship to glomerular filtration rate (gfr) independent of other risk factors [1]. |
| PubMedID- 26236158 | Anemia is an independent risk factor for development of cardiovascular diseases in patients with chronic kidney disease. |
| PubMedID- 25093403 | Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 24231387 | The age-rage pathway and its relation to cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21448530 | [assessment and management of cardiovascular disease in patients with chronic kidney disease]. |
| PubMedID- 25018979 | chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. |
| PubMedID- 21529268 | Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21562144 | Background: markers of collagen turnover have not been well studied in the context of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 24441913 | Aim: vascular calcification, an independent risk factor for cardiovascular disease in patients with chronic kidney disease(ckd), refers to the mineralization of vascular smooth muscle cells(vsmcs) caused by phenotypic changes toward osteoblast-like cells. |
| PubMedID- 22749861 | Aims: proteinuria is an independent risk factor for cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 21750584 | Cardiovascular disease in chronic kidney disease. |
| PubMedID- 21331317 | Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management. |
| PubMedID- 22214476 | Management of cardiovascular disease in chronic kidney disease: implications for managed care. |
| PubMedID- 20884698 | Objective: to quantify associations of chronic kidney disease stages with major cardiovascular disease and non-vascular mortality in the general adult population. |
| PubMedID- 26264647 | Type 4 cardiorenal syndrome (crs) is a life-threatening world health problem in which chronic kidney disease leads to progressive cardiovascular disease. |
| PubMedID- 20586902 | Screening for cardiovascular disease in patients with advanced chronic kidney disease. |
| PubMedID- 21647319 | Vitamin d deficiency appears to be an underestimated risk factor for cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21063202 | Background and objective: whether treatment with vitamin d receptor activators contributes to cardiovascular disease in patients with chronic kidney disease is a matter of debate. |
| PubMedID- 24129557 | Lipoprotein(a) is one of the strongest genetically determined risk factors for cardiovascular disease, and patients with chronic kidney disease have major disturbances in lipoprotein(a) metabolism. |
| PubMedID- 21541471 | Assessment and management of cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 25030514 | Stroke and cerebrovascular diseases in patients with chronic kidney disease. |
| PubMedID- 24157604 | Exciting new discoveries have highlighted fgf-23 as an independent risk factor for cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 22780692 | Cardiovascular disease in chronic kidney disease: untying the gordian knot. |
| PubMedID- 26354563 | The objective of this study is to determine the prevalence of peripheral vascular disease (pvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 26500541 | The patient was known to have longstanding hypertension with stage 2 chronic kidney disease due to hypertensive/vascular disease. |
| PubMedID- 24766515 | Cdata adjusted for age, sex, dyslipidemia, diabetes mellitus, chronic kidney disease, history of cardiovascular disease, and changes in the number and dose of antihypertensive drugs (other than olmesartan) during the 16-week follow-up period. |
| PubMedID- 22470397 | Proteinuria is an important risk factor not only for progression of renal failure but also for the development of cardiovascular disease in patients with chronic kidney disease (ckd) [17]. |
| PubMedID- 23206977 | Accelerated atherosclerosis and arterial stiffness are the two leading causes of increased cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21876352 | Background: cardiovascular disease in chronic kidney disease (ckd) has peculiar characteristics. |
| PubMedID- 21420113 | Long-term prospective studies and closer followup of donors are needed to identify its implications, given the associated risk of cardiovascular diseases with chronic kidney disease in the general population. |
| PubMedID- 26133318 | Association between ophthalmological changes and cardiovascular diseases in patients with chronic kidney disease undergoing hemodialysis. |
| PubMedID- 26037625 | Earlier reports confirmed the association of cca-imt with coronary artery calcium score (cacs) and cardiovascular disease not only in patients with chronic kidney disease [10] but also in patients with diabetes type 2 [22] and rheumatoid arthritis [27]. |
| PubMedID- 25874808 | Discussion: given the high burden of cardiovascular disease in women with chronic kidney disease, this study will help guide clinical practice by summarizing current evidence on the use of hormone therapy for prevention of all-cause mortality, cardiovascular mortality, and cardiovascular morbidity in this population. |
| PubMedID- 26430136 | Renovascular disease (rvd) can lead to hypertension and chronic kidney disease (ckd). |
| PubMedID- 25550968 | Asymmetric dimethylarginine (adma) has been involved in the development mechanism of cardiovascular disease (cvd) in patients with chronic kidney disease. |
| PubMedID- 22629024 | Risk factors of cardiovascular disease among children with chronic kidney disease in gaza strip. |
| PubMedID- 24055267 | Background and aims: p-cresyl sulfate (pcs) and indoxyl sulfate (is) were not only novel but essential factors associated with cardiovascular disease and mortality in patients with chronic kidney disease and hemodialysis. |
| PubMedID- 26426087 | Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. |
| PubMedID- 26374599 | Insulin resistance (ir) is a novel cardiovascular risk factor that has been implicated in the pathogenesis of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 26312829 | Background: hyperphosphataemia is a risk factor for accelerated cardiovascular disease in chronic kidney disease. |
| PubMedID- 23120811 | High incidence of cardiovascular diseases in patients with chronic kidney disease (ckd) can not soley be explained by traditional risk factors. |
| PubMedID- 25830914 | In this pilot study transcriptome analysis of peripheral blood monocytes was used to identify in an unprejudiced manner which factors could be discriminative for cardiovascular disease in patients with chronic kidney disease on hemodialysis. |
| PubMedID- 25874106 | Therefore, hyperphosphataemia is a widely recognized risk factor for mortality and cardiovascular disease in patients with chronic kidney disease (ckd) [1]. |
| PubMedID- 23451044 | The high prevalence of cardiovascular disease in chronic kidney disease (ckd) stage 5 d, i.e. |
| PubMedID- 21556311 | Target diseases were knee and/or hip osteoarthritis, poliomyelitis, chronic kidney disease, discomforts of pregnancy, cardiovascular diseases, and rotator cuff tears. |
| PubMedID- 23113674 | Aim: the current data have proven the pivotal role of inflammation in the development of atherosclerosis and cardiovascular diseases in patients with chronic kidney disease (ckd). |
| PubMedID- 20884696 | As stroke is a leading cause of mortality and morbidity worldwide, and several strategies, such as blood pressure control and use of statins and aspirin, may reduce subsequent cardiovascular disease in patients with chronic kidney disease, it is important to identify people at potential high risk, then appropriate therapy can be applied.7 8 we carried out a systematic review and meta-analysis to determine whether a link exists between reduced egfr and incident stroke and the magnitude of any relation. |